Related Experiment Videos
Para-aortic node sampling in small (3-cm or less) stage IB invasive cervical cancer
B Patsner1, T V Sedlacek, J L Lovecchio
1Department of Gynecologic Oncology, Monmouth and Riverview Medical Centers, Red Bank, New Jersey 07701.
Gynecologic Oncology
|January 1, 1992
Summary
Para-aortic node sampling in early-stage cervical cancer is rarely necessary. Only 2 of 125 patients had metastases, suggesting selective sampling for suspicious nodes in radical hysterectomy cases.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
Background:
- Cervical cancer staging is crucial for treatment planning.
- Radical hysterectomy with lymphadenectomy is a standard treatment for early-stage cervical cancer.
- The role of para-aortic lymph node sampling in early-stage disease remains debated.
Purpose of the Study:
- To evaluate the incidence of para-aortic lymph node metastasis in patients with FIGO stage IB cervical cancer.
- To determine if routine para-aortic node sampling is warranted in this patient population.
Main Methods:
- Retrospective review of 125 patients with FIGO stage IB cervical cancer (≤3 cm).
- All patients underwent radical hysterectomy, bilateral pelvic lymphadenectomy, and para-aortic node sampling.
- Pathological analysis of pelvic and para-aortic lymph nodes for metastases.
Main Results:
- Only 2 out of 125 patients (1.6%) had para-aortic lymph node metastases.
- No patient presented with gross para-aortic nodal involvement.
- Both patients with microscopic para-aortic metastases had positive pelvic nodes.
Conclusions:
- Para-aortic node sampling may not be routinely necessary for all patients with small stage IB cervical cancer.
- Selective para-aortic node sampling could be considered for patients with suspicious pelvic or para-aortic nodes.
- This finding may help refine surgical management and reduce unnecessary procedures.